248 related articles for article (PubMed ID: 19394761)
1. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
2. Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
Whyte DB; Holbeck SL
Biochem Biophys Res Commun; 2006 Feb; 340(2):469-75. PubMed ID: 16376301
[TBL] [Abstract][Full Text] [Related]
3. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
Zeng-Rong N; Paterson J; Alpert L; Tsao MS; Viallet J; Alaoui-Jamali MA
Cancer Res; 1995 Nov; 55(21):4760-4. PubMed ID: 7585500
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
5. PIK3CA mutation and amplification in human lung cancer.
Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H
Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
Abubaker J; Bavi P; Al-Harbi S; Ibrahim M; Siraj AK; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
Oncogene; 2008 Jun; 27(25):3539-45. PubMed ID: 18193083
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
9. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
10. Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
Walls M; Baxi SM; Mehta PP; Liu KK; Zhu J; Estrella H; Li C; Zientek M; Zong Q; Smeal T; Yin MJ
Clin Cancer Res; 2014 Feb; 20(3):631-43. PubMed ID: 24240111
[TBL] [Abstract][Full Text] [Related]
11. Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.
Guo XN; Rajput A; Rose R; Hauser J; Beko A; Kuropatwinski K; LeVea C; Hoffman RM; Brattain MG; Wang J
Cancer Res; 2007 Jun; 67(12):5851-8. PubMed ID: 17575153
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
Hollestelle A; Elstrodt F; Nagel JH; Kallemeijn WW; Schutte M
Mol Cancer Res; 2007 Feb; 5(2):195-201. PubMed ID: 17314276
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA gene amplification in Japanese non-small cell lung cancer.
Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
17. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
Bepler G; O'Briant K
Anticancer Res; 1998; 18(5A):3181-5. PubMed ID: 9858881
[TBL] [Abstract][Full Text] [Related]
18. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
Stordal B; Peters G; Davey R
Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine.
Savaraj N; Wu C; Wangpaichitr M; Kuo MT; Lampidis T; Robles C; Furst AJ; Feun L
Int J Oncol; 2003 Jul; 23(1):173-9. PubMed ID: 12792791
[TBL] [Abstract][Full Text] [Related]
20. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.
Brenner S; Klameth L; Riha J; Schölm M; Hamilton G; Bajna E; Ausch C; Reiner A; Jäger W; Thalhammer T; Buxhofer-Ausch V
Cancer Lett; 2015 Jan; 356(2 Pt B):517-24. PubMed ID: 25301452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]